Amarin Corporation plc (AMRN) is around the bottom of the Biotechnology industry according to InvestorsObserver. AMRN received an overall rating of 34, which means that it scores higher than 34 percent of all stocks. Amarin Corporation plc also achieved a score of 26 in the Biotechnology industry, putting it above 26 percent of Biotechnology stocks. Biotechnology is ranked 35 out of the 148 industries.

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

Amarin Corporation plc (AMRN) stock is trading at $4.97 as of 12:11 PM on Thursday, Dec 3, a rise of $0.13, or 2.79% from the previous closing price of $4.84. The stock has traded between $4.84 and $5.06 so far today. Volume today is less active than usual. So far 3,157,880 shares have traded compared to average volume of 6,785,044 shares.

Click Here to get the full Stock Score Report on Amarin Corporation plc (AMRN) Stock.

Read more:
Where Does Amarin Corporation plc (AMRN) Stock Fall in the Biotechnology Field? - InvestorsObserver